Correlation Between RepliCel Life and Royal Bank

Can any of the company-specific risk be diversified away by investing in both RepliCel Life and Royal Bank at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RepliCel Life and Royal Bank into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between RepliCel Life Sciences and Royal Bank of, you can compare the effects of market volatilities on RepliCel Life and Royal Bank and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RepliCel Life with a short position of Royal Bank. Check out your portfolio center. Please also check ongoing floating volatility patterns of RepliCel Life and Royal Bank.

Diversification Opportunities for RepliCel Life and Royal Bank

-0.9

Correlation Coefficient

RepliCel Life  Royal Bank

Pay attention - limited upside

The 3 months correlation between RepliCel and Royal is -0.9. Overlapping area represents the amount of risk that can be diversified away by holding RepliCel Life Sciences and Royal Bank of in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Royal Bank and RepliCel Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RepliCel Life Sciences are associated (or correlated) with Royal Bank. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Royal Bank has no effect on the direction of RepliCel Life i.e., RepliCel Life and Royal Bank go up and down completely randomly.

Pair Corralation between RepliCel Life and Royal Bank

Given the investment horizon of 90 days RepliCel Life Sciences is expected to under-perform the Royal Bank. In addition to that, RepliCel Life is 57.46 times more volatile than Royal Bank of. It trades about -0.04 of its total potential returns per unit of risk. Royal Bank of is currently generating about 0.12 per unit of volatility. If you would invest  2,492  in Royal Bank of on September 19, 2024 and sell it today you would earn a total of  72.00  from holding Royal Bank of or generate 2.89% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

RepliCel Life Sciences  vs.  Royal Bank of

RepliCel Life Sciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days RepliCel Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Royal Bank

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Royal Bank of are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Royal Bank is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with RepliCel Life and Royal Bank

The main advantage of trading using opposite RepliCel Life and Royal Bank positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RepliCel Life position performs unexpectedly, Royal Bank can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Royal Bank will offset losses from the drop in Royal Bank's long position.

The idea behind RepliCel Life Sciences and Royal Bank of pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.